IGM BIOSCIENCES INC's ticker is IGMS and the CUSIP is 449585108. A total of 81 filers reported holding IGM BIOSCIENCES INC in Q2 2023. The put-call ratio across all filers is 0.80 and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q3 2023 | $2,413,960 | +0.1% | 289,097 | +10.7% | 0.00% | – |
Q2 2023 | $2,411,328 | -23.6% | 261,249 | +13.7% | 0.00% | – |
Q1 2023 | $3,157,534 | -59.0% | 229,806 | -49.2% | 0.00% | – |
Q4 2022 | $7,693,794 | +52.4% | 452,310 | +103.8% | 0.00% | – |
Q3 2022 | $5,047,000 | +49.5% | 221,950 | +18.5% | 0.00% | – |
Q2 2022 | $3,376,000 | -26.4% | 187,261 | +9.1% | 0.00% | – |
Q1 2022 | $4,586,000 | -78.6% | 171,582 | -76.6% | 0.00% | -100.0% |
Q4 2021 | $21,461,000 | -50.3% | 731,720 | +11.5% | 0.00% | -50.0% |
Q3 2021 | $43,140,000 | -11.6% | 656,023 | +11.8% | 0.00% | -33.3% |
Q2 2021 | $48,825,000 | -7.4% | 586,838 | -14.6% | 0.00% | 0.0% |
Q1 2021 | $52,703,000 | +9.6% | 687,215 | +26.2% | 0.00% | 0.0% |
Q4 2020 | $48,080,000 | +97.9% | 544,573 | +65.4% | 0.00% | +50.0% |
Q3 2020 | $24,296,000 | +8.7% | 329,166 | +7.5% | 0.00% | 0.0% |
Q2 2020 | $22,346,000 | +358.4% | 306,116 | +252.6% | 0.00% | – |
Q1 2020 | $4,875,000 | +133.3% | 86,813 | +58.5% | 0.00% | – |
Q4 2019 | $2,090,000 | – | 54,775 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Redmile Group, LLC | 2,971,542 | $24,812,376 | 1.18% |
GREAT POINT PARTNERS LLC | 615,317 | $5,137,897 | 0.94% |
Artal Group S.A. | 2,522,244 | $21,061 | 0.90% |
Opaleye Management Inc. | 261,000 | $2,179,350 | 0.71% |
Samsara BioCapital, LLC | 154,664 | $1,291,444 | 0.40% |
Bruce & Co., Inc. | 120,000 | $1,002,000 | 0.34% |
Rhenman & Partners Asset Management AB | 200,000 | $1,670,000 | 0.18% |
Eagle Bay Advisors LLC | 44,635 | $372,702 | 0.17% |
RA Capital Management | 937,500 | $7,828,125 | 0.15% |
Baker Brothers Advisors | 3,157,764 | $26,367,329 | 0.15% |